Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis.

doi:10.1007/s00438-014-0941-2

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis.

Molecular genetics and genomics : MGG - 1 Apr 2015

Ye Xiang-Hua, Song Liang, Peng Ling, Bu Zhibin, Yan Sen-Xiang, Feng Jie, Zhu Xin-Li, Liao Xin-Biao, Yu Xue-Lin, Yan Danfang

Abstract excerpt

The previous, published data on the association between CYP2E1 RsaI (rs2031920), DraI (rs6413432) polymorphisms and lung cancer risk remained controversial. Hence, we performed a meta-analysis to investigate the association between lung cancer and CYP2E1 RsaI (5,074 cases and 6,828 controls from 34 studies), and CYP2E1 DraI (2,093 cases and 2,508 controls from 16 studies) in different inheritance models. Overall,...

Topics

Adenocarcinoma
Case-Control Studies
Cytochrome P-450 CYP2E1
Gene Frequency
Genetic Association Studies
Genetic Predisposition to Disease
Humans
Lung Neoplasms

Source

Open in PubMed

Identifiers

PMID: 25336053
DOI: 10.1007/s00438-014-0941-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Polymorphism, Restriction Fragment Length

Polymorphism, Single Nucleotide

Risk